Literature DB >> 17442283

CD36 and macrophages in atherosclerosis.

Sophie Collot-Teixeira1, Juliette Martin, Chris McDermott-Roe, Robin Poston, John Louis McGregor.   

Abstract

CD36 is a multi-ligand scavenger receptor present on the surface of a number of cells such as platelets, monocytes/macrophages, endothelial and smooth muscle cells. Monocyte/macrophage CD36 has been shown to play a critical role in the development of atherosclerotic lesions by its capacity to bind and endocytose oxidized low density lipoproteins (OxLDL), and it is implicated in the formation of foam cells. However, the significance of CD36 in atherosclerosis has recently been called into question by different studies, and therefore its exact role still needs to be clarified. The aim of this article is to carefully review the importance of CD36 as an essential component in the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442283     DOI: 10.1016/j.cardiores.2007.03.010

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  110 in total

1.  oxHDL decreases the expression of CD36 on human macrophages through PPARgamma and p38 MAP kinase dependent mechanisms.

Authors:  Jingyi Ren; Wenying Jin; Hong Chen
Journal:  Mol Cell Biochem       Date:  2010-05-11       Impact factor: 3.396

2.  Association of CD36 gene variants and metabolic syndrome in Iranians.

Authors:  Azita Zadeh-Vakili; Bita Faam; Maryam S Daneshpour; Mehdi Hedayati; Fereidoun Azizi
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-02

3.  Commentary on Myers et al.: growing role of the innate immunity receptor CD36 in central nervous system diseases.

Authors:  Lidia Garcia-Bonilla; Laibaik Park; Costantino Iadecola
Journal:  Exp Neurol       Date:  2014-08-23       Impact factor: 5.330

4.  Concentration-Dependent Diversifcation Effects of Free Cholesterol Loading on Macrophage Viability and Polarization.

Authors:  Xiaoyang Xu; Aolin Zhang; Ningjun Li; Pin-Lan Li; Fan Zhang
Journal:  Cell Physiol Biochem       Date:  2015-08-28

5.  Implication of lipoprotein associated phospholipase A2 activity in oxLDL uptake by macrophages.

Authors:  Konstantinos P Markakis; Maria K Koropouli; Stavroula Grammenou-Savvoglou; Ewoud C van Winden; Andromaxi A Dimitriou; Constantinos A Demopoulos; Alexandros D Tselepis; Eleni E Kotsifaki
Journal:  J Lipid Res       Date:  2010-03-23       Impact factor: 5.922

6.  CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs.

Authors:  Wei Li; Maria Febbraio; Sekhar P Reddy; Dae-Yeul Yu; Masayuki Yamamoto; Roy L Silverstein
Journal:  J Clin Invest       Date:  2010-10-11       Impact factor: 14.808

7.  Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL.

Authors:  Yong Yang; Yan-Fu Wang; Xiao-Fang Yang; Zhao-Hui Wang; Yi-Tian Lian; Ying Yang; Xiao-Wei Li; Xiang Gao; Jian Chen; Yan-Wen Shu; Long-Xian Cheng; Yu-Hua Liao; Kun Liu
Journal:  J Lipid Res       Date:  2012-10-24       Impact factor: 5.922

8.  Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis.

Authors:  Allison B Reiss; David W Wan; Kamran Anwar; Joan T Merrill; Peter A Wirkowski; Nidhi Shah; Bruce N Cronstein; Edwin S L Chan; Steven E Carsons
Journal:  Exp Biol Med (Maywood)       Date:  2009-01-14

9.  Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36.

Authors:  Fenghua Zhou; Yunyun Pan; Zhiyong Huang; Yuhua Jia; Xiaoshan Zhao; Yuyao Chen; Jianxin Diao; Qiang Wan; Xiaobing Cui
Journal:  Cell Stress Chaperones       Date:  2013-03-15       Impact factor: 3.667

10.  Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival Cells.

Authors:  Laura Soriano-Romaní; Laura Contreras-Ruiz; Laura García-Posadas; Antonio López-García; Sharmila Masli; Yolanda Diebold
Journal:  J Ocul Pharmacol Ther       Date:  2015-07-08       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.